Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
A woman is evaluated by psychiatry on postpartum day 2 after staff noticed her talking to the mirror in her room and not showing affection to her newborn child. Case shows ethical decisions made when managing mental illness during pregnancy.
Researchers examined the relationship between maternal age and childhood ADHD to determine which factors may mediate or confound the association.
Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.
Authors say respectful maternity care may help address maternal morbidity in Black women.
Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.
ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.
Dr. Ehrlich reviews the evidence of 3 recent studies that evaluate the risk of fracking and health outcomes in infants, management of hypertension in pregnancy, and cardiac risk of eye surgery.
Researchers assessed the association between autoimmune atrophic gastritis and pregnancy complications.
Ratio had better performance for predicting preeclampsia with severe features than standard clinical measures.